Biogen Inc. (Nasdaq: BIIB) to Ring The Nasdaq Stock Market Opening Bell

ADVISORY, May 07, 2015 (GLOBE NEWSWIRE) --

What: 

Biogen Inc. (Nasdaq: BIIB), one of the world’s oldest independent biotechnology companies, will visit the Nasdaq MarketSite in Times Square.

In honor of the occasion, Paul J. Clancy, Executive Vice President, Finance and Chief Financial Officer will ring the Opening Bell.

Where:

Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio

When:

Friday, May 8, 2015 – 9:15 a.m. to 9:30 a.m. ET 

Biogen Inc. Media Contact:Kate Niazi-Sai(781) 464-3260[email protected]  

Nasdaq MarketSite:Christine Barna(646) 441-5310[email protected]  

Feed Information:Fiber Line (Encompass Waterfront): 4463

Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK 

Social Media:

For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ.

For photos from ceremonies and events visit our Instagram Page: http://instagram.com/nasdaq 

For news tweets, please visit our Twitter page at: http://twitter.com/nasdaq 

For exciting viral content and ceremony photos visit Tumblr Page: http://nasdaq.tumblr.com/  

Webcast:

A webcast of the Nasdaq Opening Bell will be available at: https://new.livestream.com/nasdaq/live or http://www.nasdaq.com/about/marketsitetowervideo.asx  

Photos: 

To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.

About Biogen Inc. (Nasdaq: BIIB):

Through cutting-edge science and medicine, Biogen discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hematologic conditions and autoimmune disorders. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies, and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies. For product labeling, press releases and additional information about the company, please visit www.biogen.com.

About NASDAQ-100 Index®:

The NASDAQ-100 Index, launched in January 1985, is one of the most widely followed benchmarks in the world. The NASDAQ-100 Index is the basis of the PowerShares QQQ Trust (Nasdaq: QQQ) which aims to provide investment results that, before expenses, correspond with the NASDAQ-100 Index's performance. In addition, options, futures and structured products based on the NASDAQ-100 Index and the PowerShares QQQ Trust trade on various exchanges.

About Nasdaq:

Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,500 listed companies with a market value of approximately $9.5 trillion and more than 10,000 corporate clients. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

-NDAQA-

 

Source: The NASDAQ OMX Group, Inc.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Stocks end near flat as investors assess earnings, data
• FendX Announces Corporate Update
• ContextLogic Completes Sale of Substantially All Operating Assets and Liabilities Associated with Wish to Qoo10